Multiple sclerosis epidemiology and demographics

Revision as of 23:54, 27 November 2018 by Fahimeh Shojaei (talk | contribs)
Jump to navigation Jump to search

Multiple sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Alternative Therapies

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple sclerosis epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple sclerosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple sclerosis epidemiology and demographics

CDC on Multiple sclerosis epidemiology and demographics

Multiple sclerosis epidemiology and demographics in the news

Blogs on Multiple sclerosis epidemiology and demographics

Directions to Hospitals Treating Multiple sclerosis

Risk calculators and risk factors for Multiple sclerosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Irfan Dotani

Overview

The majority of multiple sclerosis cases are reported in northern Europe, continental North America, and Australasia, which is about one of every 1000 citizens. Factors including sunlight exposure, climate, diet, toxins, genetic factors, geomagnetism, childhood environmental factors, and infections have been proved to cause the differences in MS prevalence. MS is at least two times more common among women than men. The onset of symptoms is mostly between the age of fifteen to forty years, rarely before age fifteen or after age sixty.

Epidemiology and Demographics

The majority of multiple sclerosis cases are reported in northern Europe, continental North America, and Australasia, which is about one of every 1000 citizens while there is a lower frequency of people suffering from Multiple Sclerosis among citizens of the Arabian Peninsula, Asia, and continental South America. In addition, in sub-Saharan Africa, MS is extremely rare.[1] factors including sunlight exposure, climate, diet, toxins, genetic factors, geomagnetism, Childhood environmental factors and infections have been proved to cause this differences in MS prevalence. Several studies demonstrated that if immigration occurs before the age of fifteen, the migrant's susceptibility to MS will be equal to that region's native people, But if migration occurs after the age of fifteen, the migrant's susceptibility will remain equal to his home country.[2]

genetic factors are an important risk factors to MS disease. It is estimated that among MS patients siblings, one can be affected eventually. The identical twins of MS-affected individuals, almost half of them will develop MS, but in fraternal twins it's one of twenty.if one of the parents is affected by MS, the risk of developing MS for each child is about one in forty.[3]

it is important to say that some studies on related diseases have shown that some diseases which were formerly considered MS cases are not MS at all. all the studies before 2004 can be affected because of inability to distinguish MS and Devic's disease (NMO).[4]

Incidence

Prevalence

The prevalence of MS varies among countries. according to some studies MS occurs mostly in Caucasians while it is rare in the Native American tribes of North America, Australian Aborigines and the Māori of New Zealand. Among countries Scotland seems to have the highest rate of MS in the world.[5] We can conclude that due to genetic susceptibility, lifestyle and different culture, the development of this disease is not equal in various regions.

Case-fatality rate/Mortality rate

Age

The onset of symptoms is mostly between the age of fifteen to forty years, rarely before age fifteen or after age sixty.

Race

MS prevalence is lower in African Americans, Mexicans, Japanese, Chinese and Filipinos people rather than white men.[6]

Gender

autoimmune disorders such as MS is at least two times more common among women than men but this difference will disappear after the age of 50 and in children reach three females for each male.

References

  1. Epidemiology and multiple sclerosis. a personal review
  2. Marrie, RA. Environmental risk factors in multiple sclerosis etiology. Lancet Neurol. 2004 Dec;3(12):709-18. Review. PMID 15556803
  3. Sadovnick, AD, Ebers, GC, Dyment, DA, Risch, NJ. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347:1728. PMID 8656905
  4. Weinshenker B (2005). "Western vs optic-spinal MS: two diseases, one treatment?". Neurology. 64 (4): 594–5. PMID 15728277.
  5. Rothwell PM, Charlton D (1998). "High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition". J. Neurol. Neurosurg. Psychiatr. 64 (6): 730–5. PMID 9647300.

Template:WH Template:WS